Evidence map›Paper›PMID 22108506›Full record

ReviewPhysiology & behavior2012

Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems.

Olivier George, Michel Le Moal, George F Koob

Abstract readReview
In one paragraph

Review in Physiology & behavior, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed.

  1. Trial
  2. A history of addiction through the six editions of Kandel'sFrontiers in behavioral neuroscience · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Withdrawal: A key consideration in evaluating whether highly processed foods are addictive.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2022
    Review
  15. Indigenous Land-Based Approaches to Well-Being: TheInternational journal of environmental research and public health · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Tobacco Use Disorder.The Medical clinics of North America · 2022
    Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Olivier GeorgeCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037, USA. ogeorge@scripps.edu
Michel Le Moal
George F Koob

Funding

Viral Vector CoreP60AA006420 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ERIC P ZORRILLA · 2003 to 2026
$46.3M
SYSTEMIC NEUROPHARMACOLOGYP50AA006420 · NIAAA · SCRIPPS RESEARCH INSTITUTE · PI KOOB, GEORGE F · 1985 to 2002
$5.1M
NEURONAL SUBSTRATES OF COCAINE REWARDR01DA004398 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI GEORGE, OLIVIER · 1987 to 2014
$4.9M
NEUROPHARMACOLOGY OF ETHANOL REINFORCEMENTR01AA008459 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI GEORGE, OLIVIER · 1990 to 2013
$4.2M
DOPAMINE PARTIAL AGONISTS AND PSYCHOSTIMULANT DEPENDENCER01DA010072 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI KOOB, GEORGE F. · 1997 to 2011
$3.6M
CENTRAL MECHANISMS OF OPIATE REINFORCEMENT &DEPENDENCER01DA004043 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI KOOB, GEORGE F. · 1986 to 2008
$3.0M
Central mechanisms of nicotine reinforcement and dependenceR01DA023597 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI KOOB, GEORGE F. · 2008 to 2012
$1.9M
NEUROPHARMACOLOGY OF ETHANOL REINFORCEMENTR37AA008459 · NIAAA · SCRIPPS RESEARCH INSTITUTE · PI KOOB, GEORGE F · 1993 to 2002
$788k
NIAAA NIH HHS AA06420NIAAA NIH HHS AA08459NIAAA NIH HHS P50 AA006420NIAAA NIH HHS P60 AA006420NIAAA NIH HHS R01 AA008459NIAAA NIH HHS R37 AA008459NIDA NIH HHS DA023597NIDA NIH HHS DA04343NIDA NIH HHS DA04398NIDA NIH HHS DA10072NIDA NIH HHS R01 DA004043NIDA NIH HHS R01 DA004398NIDA NIH HHS R01 DA010072NIDA NIH HHS R01 DA023597
6 · The paper itself

Abstract

Allostasis, originally conceptualized to explain persistent morbidity of arousal and autonomic function, is defined as the process of achieving stability through physiological or behavioral change. Two types of biological processes have been proposed to describe the mechanisms underlying allostasis in drug addiction, a within-system adaptation and a between-system adaptation. In the within-system process, the drug elicits an opposing, neutralizing reaction within the same system in which the drug elicits its primary and unconditioned reinforcing actions, while in the between-system process, different neurobiological systems that the one initially activated by the drug are recruited. In this review, we will focus our interest on alterations in the dopaminergic and corticotropin releasing factor systems as within-system and between-system neuroadaptations respectively, that underlie the opponent process to drugs of abuse. We hypothesize that repeated compromised activity in the dopaminergic system and sustained activation of the CRF-CRF1R system with withdrawal episodes may lead to an allostatic load contributing significantly to the transition to drug addiction.

Indexed as

AllostasisAnimalsCorticotropin-Releasing HormoneDopamineHumansMotivationSubstance-Related DisordersSubstance Withdrawal SyndromeCorticotropin-Releasing HormoneDopamine

Identifiers

PMID22108506
PMCPMC3288230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.